why choose us

First received: November 10, 2023

Clinical Trial: Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Gastrointestinal Neoplasm

Study Type: INTERVENTIONAL


Official Title: Prospective Single Centre, Post Market, Randomized Controlled Trial to Demonstrate Feasibility, Safety and Efficacy, of a Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection

Brief Summary: The goal of this prospective, single centre, 1:1, Post Market, randomized controlled, Investigator Initiated trial, is to compare the feasibility, safety efficacy, and clinical outcomes of colonic endoscopic submucosal dissection (ESD) utilizing a novel rigidizing overtube called Pathfinder® Endoscope Overtube (Neptune Medical, Burlingame California, USA) device in comparison to conventional ESD.The research team hypothesize that with utilizing a novel rigidizing overtube the procedure time including dissection…

Read more